Fargo Enterprises (ASX:FGO) - Outgoing Executive Director, Dr Catriona Wallace
Outgoing Executive Director, Dr Catriona Wallace
Source: Ode Management
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Fargo Enterprises (FGO) completes public offer raising $6 million through the issuing of 300 million new shares at an issue price 0.2 cents per share
  • The company says proceeds raised from the public offer will be used to fund diamond exploration activities across its portfolio of projects in Western Australia’s Kimberly region
  • In other news, Fargo will be renamed Odessa Minerals and is looking to be reinstated on the ASX under the proposed ticker code ODE
  • The company says its working closely with the ASX to satisfy its compliance conditions with reinstatement to official quotation anticipated for January 18 2022
  • Shares have been trading flat at 0.5 cents

Fargo Enterprises (FGO) has completed a public offer raising $6 million through the issuing of 300 million new shares at an issue price 0.2 cents per share.

The company said proceeds raised from the public offer will be used to fund diamond exploration activities across its portfolio of projects in Western Australia’s Kimberly region.

In other news, Fargo will be renamed Odessa Minerals and is looking to be reinstated on the ASX under the proposed ticker code ODE.

The company said it’s working closely with the ASX to satisfy its compliance conditions with reinstatement to official quotation anticipated for January 18, 2022.

The company also said its diamond exploration activities are scheduled to commence upon reinstatement to the ASX.

Meanwhile Dr Catriona Wallace and Mr Phillip Coulson will resign upon completion of the transaction as Executive Director and Non-Executive Director effective January 17 2022.

Shares were in the grey at 0.5 cents at market close.

fgo by the numbers
More From The Market Online

LTR Pharma’s SPONTAN investigation in pulmonary arterial hypertension approved

LTR Pharma has received approval for an investigator-initiated clinical study evaluating SPONTAN in patients with newly…

Wisr delivers record growth and upgrades FY27 guidance

Wisr has reported that its loan book reached $1.2 billion in Q1FY27, increasing 40% to $1,211…

Aquirian receives increased equipment funding facility from NAB to $25M

Aquirian has obtained approval from the National Australia Bank for an increase to the group’s master…
HotCopper Daily Market Trends Graphic

Thursday’s HotCopper trends: AXP Energy, Tambourah Metals, Santos and other daily topics

With more than 600k average monthly users on the HotCopper forums, each and every discussion can…